Research Articles | Page 86 | Aplastic Anemia & MDS International Foundation

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title	Original Publication Date	Journal	Bone Marrow Disease
Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1/2 trial	Jun 2019	The Lancet Haematology	myelodysplastic syndromes (MDS)
Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes	Jan 2020	The New England Journal of Medicine	myelodysplastic syndromes (MDS)
Safety and efficacy of azacitidine in elderly patients with intermediate to high-risk myelodysplastic syndromes	Jan 2017	Ther Adv Hematol	myelodysplastic syndromes (MDS)
Azacitidine in the management of patients with myelodysplastic syndromes.	Dec 2012	Ther Adv Hematol	myelodysplastic syndromes (MDS)
Management of thrombosis in paroxysmal nocturnal hemoglobinuria: a clinician's guide	Mar 2017	Ther Adv Hematol	paroxysmal nocturnal hemoglobinuria (PNH)
Eculizumab in the management of paroxysmal nocturnal hemoglobinuria: patient selection and special considerations	Aug 2016	Ther Clin Risk Manag	paroxysmal nocturnal hemoglobinuria (PNH)
Ravulizumab: a novel C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria	Sep 2019	Therapeutic Advances in Hematology	paroxysmal nocturnal hemoglobinuria (PNH)
Management of myelodysplastic syndromes after failure of response to hypomethylating agents	May 2019	Therapeutic Advances in Hematology	myelodysplastic syndromes (MDS)
The dysfunction of platelets in paroxysmal nocturnal hemoglobinuria	Jul 2016	Thromb Res	paroxysmal nocturnal hemoglobinuria (PNH)
Aplastic anemia and risk of deep vein thrombosis and pulmonary embolism: A nationwide cohort study	Jan 2017	Thromb Res	aplastic anemia